The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study
- PMID: 31491497
- DOI: 10.1016/j.jtbi.2019.109996
The long-term population impact of endoscopic screening programmes on disease burdens of gastric cancer in China: A mathematical modelling study
Abstract
Background: Gastric cancer (GC) incidence and mortality in China remained high due to delayed diagnosis and accounted for about half of the world's GC cases and deaths. Early detection with endoscopic screening and consequent timely treatment can significantly improve survival. This study aimed to explore the long-term population impact of endoscopic screening on national GC disease burdens in China.
Methods: Most of previous studies investigated the disease burdens of cancer using Markov model or age-period-cohort (APC) model, which are difficult to estimate the population size of undiagnosed cases. In this paper, we proposed a new dynamic compartmental model based on GC natural history and calibrated model outputs to diagnosed GC cases and GC-related death counts using Markov Chain Monte Carlo methods. We investigated the impact of screening strategies with various coverage (10%, 40%, 70%) and frequency (every 1, 3, 5 years) on disease burdens.
Results: We estimated that 2.22 (95%CI: 1.97-2.47) million Chinese are living with GC in 2019, among which, 42.7% (40.3-45.0%) remained undiagnosed. Without systematic screening, we projected 10.46 (9.07-11.86) million incident cases and 7.35 (6.59-8.11) million GC-related deaths over the next 30 years (2019-2049). Screening with coverage rate at 10%, 40%, 70% every 3 years could prevent 0.85 (0.63-1.06), 2.32 (1.79-2.86), and 3.04 (2.38-3.70) million incident cases, and prevent 1.17 (1.01-1.32), 3.08 (2.70-3.46), and 3.93 (3.46-4.40) million deaths respectively, compared with 'no screening' scenario. Screening would substantially increase the number of diagnosed GC cases within the first three years of program initiation, but this number would quickly reduce below 'no screening' scenario. Three-yearly screening at the above coverage rates would reduce the proportion of undiagnosed GC cases to 38.8% (36.9-40.7%), 25.5% (23.4-27.6%), and 17.8% (16.0-19.6%) by 2049, respectively. Delaying implementation of the screening program would substantially reduce its effectiveness.
Conclusions: Initiating national endoscopic screening programmes would likely have a major effect on reducing GC incidence and mortality in China. Health resources should be substantially increased and directed to treatment of GC to cope with the initial rise in diagnosed GC cases.
Keywords: Deaths; Dynamic compartmental model; Endoscopic screening; Gastric cancer; Incident cases; Prevalent cases.
Copyright © 2019 Elsevier Ltd. All rights reserved.
Similar articles
-
Nationwide gastric cancer prevention in China, 2021-2035: a decision analysis on effect, affordability and cost-effectiveness optimisation.Gut. 2022 Dec;71(12):2391-2400. doi: 10.1136/gutjnl-2021-325948. Epub 2022 Jul 28. Gut. 2022. PMID: 35902213
-
Effectiveness of endoscopic gastric cancer screening in a rural area of Linzhou, China: results from a case-control study.Cancer Med. 2016 Sep;5(9):2615-22. doi: 10.1002/cam4.812. Epub 2016 Jul 1. Cancer Med. 2016. PMID: 27367362 Free PMC article.
-
Performance of gastric cancer screening by endoscopy testing through the National Cancer Screening Program of Korea.Cancer Sci. 2011 Aug;102(8):1559-64. doi: 10.1111/j.1349-7006.2011.01982.x. Epub 2011 Jun 9. Cancer Sci. 2011. PMID: 21564421
-
Cost-effectiveness of prevention and early detection of gastric cancer in Western countries.Best Pract Res Clin Gastroenterol. 2021 Mar-Apr;50-51:101735. doi: 10.1016/j.bpg.2021.101735. Epub 2021 Feb 22. Best Pract Res Clin Gastroenterol. 2021. PMID: 33975689 Review.
-
Surveillance of Barrett's oesophagus: exploring the uncertainty through systematic review, expert workshop and economic modelling.Health Technol Assess. 2006 Mar;10(8):1-142, iii-iv. doi: 10.3310/hta10080. Health Technol Assess. 2006. PMID: 16545207 Review.
Cited by
-
Time Trend of Upper Gastrointestinal Cancer Incidence in China from 1990 to 2019 and Analysis Using an Age-Period-Cohort Model.Curr Oncol. 2022 Oct 6;29(10):7470-7481. doi: 10.3390/curroncol29100588. Curr Oncol. 2022. PMID: 36290865 Free PMC article.
-
The Feasibility of Applying Artificial Intelligence to Gastrointestinal Endoscopy to Improve the Detection Rate of Early Gastric Cancer Screening.Front Med (Lausanne). 2022 May 16;9:886853. doi: 10.3389/fmed.2022.886853. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35652070 Free PMC article. Review.
-
Ghrelin Affects Gastric Cancer Progression by Activating AMPK Signaling Pathway.Biochem Genet. 2021 Jun;59(3):652-667. doi: 10.1007/s10528-020-10022-x. Epub 2021 Jan 13. Biochem Genet. 2021. PMID: 33442814
-
Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.Cancer Manag Res. 2020 Jul 30;12:6641-6653. doi: 10.2147/CMAR.S258360. eCollection 2020. Cancer Manag Res. 2020. PMID: 32801898 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
